책임저자 | 제목/저자명/학술지명/게재년월일 |
---|---|
![]() |
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma.
Kim SJ, Ryu KJ, Park B, Yoon SE, Cho J, Park Y, Kim WS. Cancers (Basel) 2022 Nov 16 |
최신발표논문안내 |
---|
Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma.
Kim SJ, Ryu KJ, Park B, Yoon SE, Cho J, Park Y, Kim WS. Cancers (Basel) 2022 Nov 16 |